TERMIUM Plus®

The Government of Canada’s terminology and linguistic data bank.

5-[2-ETHOXY-5-(4-METHYL-1-PIPERAZINYL-SULPHONYL)-PHENYL]-1-METHYL-3-N-PROPYL-1 6-DIHYDRO-7H-PYRAZOLO[4 3-D]PYRIMIDIN-7-ONE [1 record]

Record 1 2012-01-05

English

Subject field(s)
  • Chemical Elements and Compounds
CONT

The 446 Patent disclosure states that the patent relates to the use of a series of pyrazolo [4,3-d]pyrimidin-7-ones for the treatment of impotence. The disclosure then states that the present invention concerns the use of a compound of formula I. Formula I gives rise to approximately 260 quintillion chemical compounds. The disclosure classifies these 260 quintillion compounds into four categories: a preferred group of compounds, a more preferred group of compounds; a particularly preferred group of compounds: and a list of especially preferred individual compounds of the invention. Included in the list of especially preferred individual compounds is 5-[2-ethoxy-5-(4-methyl-1-piperazinyl-sulphonyl)-phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one or a pharmaceutically acceptable salt thereof.

OBS

H and d: these letters must be italicized.

French

Domaine(s)
  • Éléments et composés chimiques

Spanish

Save record 1

Copyright notice for the TERMIUM Plus® data bank

© Public Services and Procurement Canada, 2024
TERMIUM Plus®, the Government of Canada's terminology and linguistic data bank
A product of the Translation Bureau

Features

Language Portal of Canada

Access a collection of Canadian resources on all aspects of English and French, including quizzes.

Writing tools

The Language Portal’s writing tools have a new look! Easy to consult, they give you access to a wealth of information that will help you write better in English and French.

Glossaries and vocabularies

Access Translation Bureau glossaries and vocabularies.

Date Modified: